Lenka has international experience in legal and regulatory affairs, compliance and due diligence in the energy trading, finance, and vaping products. She holds an interdisciplinary LLM in regulation of markets from Utrecht University and a masters degree in law from the Comenius University in Bratislava. Her hobbies include sports, photography, languages and travelling.
Lenka is in charge of our coverage of regulatory developments in Europe.
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.
Do the Novel Food regulations in Europe affect your business?
CBD as a Novel Food: the future for edibles in Europe
This new CBD-Intel report examines key aspects and drivers of the edibles market itself before looking in detail at the Novel Food regulations, both at EU level and in non-EU markets: notably the UK, as well as Switzerland and Norway.
Questions it considers and answers include whether CBD really is novel, whether approvals are likely to be generic or applicant-specific, how the Novel Food Catalogue and RASFF operate, and the costs of Novel Food applications.
This report also includes a 1-hour consultation call with CBD-Intel’s analyst team.